The Nature of Dominant Mutations of Rhodopsin and Implications for Gene Therapy

Molecular Neurobiology

Volumn 28, Issue 2, 2003, Pages 149-158

  Wilson, John H ^a   Wensel, Theodore G ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Dominant mutants; Gene therapy; Mouse expression studies; Retinitis pigmentosa; Rhodopsin mutations

Indexed keywords

MUTANT PROTEIN; RHODOPSIN;

CONFERENCE PAPER; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENE THERAPY; HAPLOIDY; HETEROZYGOSITY LOSS; HUMAN; NONHUMAN; RETINA DEGENERATION; RETINA DISEASE; RETINA ROD OUTER SEGMENT; RETINITIS PIGMENTOSA; TRANSGENE; WILD TYPE;

EID: 0742321905     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1385/MN:28:2:149     Document Type: Conference Paper

References (46)

1. Weleber R.G. and Gregory-Evans K. (2001) Retinitis pigmentosa and allied disorders. In Retina (Ryan S.J., ed.), Mosby, St. Louis, MO, pp. 362-470.
2. Chong N.H.V. and Bird A.C. (1999) Management of inherited outer retinal dystrophies: present and future. Br. J. Ophthalmol. 83, 120-122.
3. Farrar G.J., Kenna P.F., and Humphries P. (2002) On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention. EMBO J. 21, 857-864.
4. Rattner A., Sun H., and Nathans J. (1999) Molecular genetics of human retinal disease. Annu. Rev. Genet. 33, 89-131.
5. Rivolta C., Sharon D., DeAngelis M.M., and Dryja T.P. (2002) Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns. Hum. Mol. Genet. 11, 1219-1227.
6. http://www.sph.uth.tmc.edu/RetNet.
7. http://eyegene.meei.harvard.edu.
8. Hargrave P.E. and McDowell J.H. (1992) Rhodopsin and phototransduction: a model system for G protein-linked receptors. FASEB J. 6, 2323-2331.
9. Millington-Ward S., O'Neill B., Tuohy G., Al-Jandal N., Kiang A.-S., Kenna P.F., et al. (1997) Strategems in vitro for gene therapies directed to dominant mutations. Hum. Mol. Genet. 6, 1415-1426.
10. Rosenfeld P.J., Cowley G.S., McGee T.L., Sandberg M.A., Berson E.L., and Dryja T.P. (1992) A null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa. Nat. Genet. 1, 209-213.
11. Lem J., Krasnoperova N.V., Calvert P.D., Kosaras B., Cameron D.A., Nicolo M., et al. (1999) Morphological, physiological, and biochemical changes in rhodopsin knockout mice. Proc. Natl. Acad. Sci. USA 96, 736-741.
12. Humphries M.M., Rancourt D., Farrar G.J., Kenna P., Hazel M., Bush R.A., et al. (1997) Retinopathy induced in mice by targeted disruption of the rhodopsin gene. Nat. Genet. 15, 216-219.
13. Lewis E.B. (1978) A gene complex controlling segmentation in Drosophila. Nature 276, 565-570.
14. Keen T.J., Inglehearn C.F., Lester D.H., Bashir R., Jay M., Bird A.C., et al. (1991) Autosomal dominant retinitis pigmentosa: four new mutations in rhodopsin, one of them in the retinal attachment site. Genomics 11, 199-205.
15. Robinson P.R., Cohen G.B., Zhukovsky E.A., and Oprian D.D. (1992) Constitutively active mutants of rhodopsin. Neuron 9, 719-725.
16. Downward J. (2003) Targeting RAS signaling pathways in cancer therapy. Nat. Rev. Cancer 3, 11-22.
17. Fain G.L. and Lisman J.E. (1993) Photoreceptor degeneration in vitamin A deprivation and retinitis pigmentosa: the equivalent light hypothesis. Exp. Eye Res. 57, 335-340.
18. Li T., Franson W.K., Gordon J.W., Berson E.L., and Dryja T.P. (1995) Constitutive activation of photo-transduction by K296E opsin is not a cause of photoreceptor degeneration. Proc. Natl. Acad. Sci. USA 92, 3551-3555.
19. Sung C.-H., Schneider B.G., Agarwal N., Pappermaster D.S., and Nathans J. (1991) Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 88, 8840-8844.
20. Illing M.E., Rajan R.S., Bence N.F., and Kopito R.R. (2002) A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system. J. Biol. Chem. 277, 34,150-34,160.
21. Rajan R.S., Illing M.E., Bence N.F., and Kopito R.R. (2001) Specificity in intracellular protein aggregation and inclusion body formation. Proc. Natl. Acad. Sci. USA 98, 13,060-13,065.
22. Tran P.B. and Miller R.J. (1999) Aggregates in neurodegenerative disease: crowds and power? Trends Neurosci. 5, 194-197.
23. Kopito R.R. (2000) Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 10, 524-530.
24. Herskowitz I. (1987) Functional inactivation of genes by dominant negative mutations. Nature 329, 219-222.
25. Milner J. and Medcalf E.A. (1991) Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell 65, 765-774.
26. Brachmann R.K., Vidal M., and Boeke J.D. (1996) Dominant-negative p53 mutations selected in yeast hit cancer hotspots. Proc. Natl. Acad. Sci. USA 93, 4091-4095.
27. Fotiadis D., Liang Y., Filipek S., Saperstein D.A., Engel A., and Palczewski K. (2003) Rhodopsin dimers in native disc membranes. Nature 421, 127-128.
28. Downer N.W. and Cone R.A. (1985) Transient dichroism in photoreceptor membranes indicates that stable oligomers of rhodopsin do not form during excitation. Biophys. J. 47, 277-284.
29. Rios C.D., Jordan B.A., Gomes I., and Devi L.A. (2001) G-protein-coupled receptor dimerization: modulation of receptor function. Pharmacol. Ther. 92, 71-87.
30. Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., et al. (1998) Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281, 1851-1854.
31. Sung C-H., Makino C., Baylor D., and Nathans J. (1994) A rhodopsin gene mutation responsible for autosomal dominant retinitis pigmentosa results in a protein that is defective in localization to the photoreceptor outer segment. J. Neuro. Sci. 14, 5818-5833.
32. Olsson J.E., Gordon J.W., Pawlyk B.S., Roof D., Hayes A., Molday R.S., et al. (1992) Transgenic mice with a rhodopsin mutation (Pro23His): A mouse model of autosomal dominant retinitis pigmentosa. Neuron 9, 815-830.
33. Frederick J.M., Krasnoperova N.V., Hoffmann K., Church-Kopish J., Ruther K., Howes K., et al. (2001) Mutant rhodopsin transgene expression on a null background. Investig. Ophthalmol. Vis. Sci. 42, 826-833.
34. Lewin A.S., Drenser K.A., Hauswirth W.W., Nishikawa S., Yasumura D., Flannery J.G., et al. (1998) Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa. Nat. Med. 4, 967-971.
35. LaVail M.M., Yasumura D., Matthes M.T., Drenser K.A., Flannery J.G., Lewin A.S., et al. (2000) Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy. Proc. Natl Acad. Sci. USA 97, 11,488-11,493.
36. Intody Z., Perkins B.D., Wilson J.H., and Wensel T.G. (2000) Blocking transcription of the human rhodopsin gene by triplex-mediated DNA photocrosslinking. Nucleic Acids Res. 28, 4283-4290.
37. Roorda A. and Williams D.R. (1999) The arrangement of the three cone classes in the living human eye. Nature 397, 520-522.
38. Liang J., Williams D.R., and Miller D.T. (1997) Super-normal vision and high-resolution imaging through adaptive optics. J. Opt. Soc. Am. 14, 2884-2892.
39. McNally N., Kenna P., Humphries M.M., Hobson A.H., Khan N.W., Bush R.A., et al. (1999) Structural and functional rescue of murine rod photoreceptors by human rhodopsin transgene. Hum. Mol. Genet. 8, 1309-1312.
40. Li T., Snyder W.K., Olsson J.E., and Dryja T.P (1996) Transgenic mice carrying the dominant rhodopsin mutation P347S: Evidence for defective vectorial transport of rhodopsin to the outer segments. Proc. Natl. Acad. Sci. USA 93, 14,176-14,181.
41. Li T., Sandberg M.A., Pawlyk B.S., Rosner B., Hayes K.C., Dryja T.P., et al. (1998) Effect of vitamin A supplementation on rhodopsin mutants threonine-17 to methionine and proline-347 to serine in transgenic mice and in cell cultures. Proc. Natl. Acad. Sci. USA 95, 11,933-11,938.
42. Naash M.I., Hollyfield J.G., Al-Ubaidi M.R., and Baehr W. (1993) Simulation of human autosomal dominant rennitis pigmentosa in transgenic mice expressing a mutated murine opsin gene. Proc. Natl. Acad. Sci. USA 90, 5499-5503.
43. Goto Y., Peachey N.S., Ripps H., and Naash M.I. (1995) Functional abnormalities in transgenic mice expressing a mutant rhodopsin gene. Investig. Ophthalmol. Vis. Sci. 36, 62-71.
44. Tan E., Wang Q., Quiambao A.B., Xu X., Qtaishat N.M., Peachey N.S., et al. (2001) The relationship between opsin overexpression and photoreceptor degeneration. Investig. Ophthalmol. Vis. Sci. 42, 589-600.
45. Chen J., Makino C.L., Peachey N.S., Baylor D.A., and Simon M.I. (1995) Mechanisms of rhodopsin inactivation in vivo as revealed by a COOH-terminal truncation mutant. Science 267, 374-377.
46. Soukharev S., Miller J.L., and Sauer B. (1999) Segmental genomic replacement in embryonic stem cells by double lox targeting. Nucleic Acids Res. 27, e21.